Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

PDMR Resignation

6 May 2025 07:00

RNS Number : 3854H
Supply@ME Capital PLC
06 May 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

6 May 2025

Supply@ME Capital plc

(the "Company", "Supply@ME" or "SYME")

PDMR Resignation

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, announces that Alice Buxton, Chief People Officer and a PDMR at Supply@ME, has resigned with effect from 24 May 2025. The Board does not intend to replace Alice at this time and in the meantime, she will work with the team to transition her responsibilities to external providers and internal resource as appropriate. 

Alessandro Zamboni, Chief Executive Officer said:

"I would like to thank Alice for her valuable contribution to the Company since she joined in 2021. Alice has been instrumental to helping the Company and the employee base navigate through challenging times, and she will be missed by myself and the team. We wish her all the best for the future."

Contact information

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com 

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSWFAIEISEFI
Date   Source Headline
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 202011:05 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSUAE Update: Official launch of the Shari’a project
30th Oct 20207:00 amRNSInventory Funding: Securitisation Issue Update
26th Oct 20207:00 amRNSPrice Monitoring Extension
22nd Oct 202011:05 amRNSSecond Price Monitoring Extn
22nd Oct 202011:00 amRNSPrice Monitoring Extension
22nd Oct 202010:09 amRNSStrategic Agreement to launch in The United States
12th Oct 202011:52 amRNSAppointment of New Auditor
9th Oct 20202:06 pmRNSSecond Price Monitoring Extn
9th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20202:05 pmRNSSecond Price Monitoring Extn
30th Sep 20202:00 pmRNSPrice Monitoring Extension
29th Sep 20209:00 amRNSPrice Monitoring Extension
28th Sep 20207:02 amRNSUpdate on Business Operations
25th Sep 202010:00 amRNSDirector/PDMR Shareholding
25th Sep 20207:00 amRNSStatement regarding Orchestra Group Call Option
24th Sep 202012:20 pmRNSHolding(s) in Company
24th Sep 202012:20 pmRNSDirector/PDMR Shareholding
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
21st Sep 20209:06 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
21st Sep 20207:00 amRNSEUR 8bn Funding Agreement with Bank acquisition
17th Sep 20207:00 amRNSResponse to erroneous media article
10th Sep 202011:05 amRNSSecond Price Monitoring Extn
10th Sep 202011:00 amRNSPrice Monitoring Extension
10th Sep 20207:00 amRNSInventory Funding and Investor Update
8th Sep 20207:00 amRNSHolding in Company
8th Sep 20207:00 amRNSDirector/PDMR Shareholding
4th Sep 20207:00 amRNSAlliance with leading Italian SME Fintech Platform
28th Aug 20207:00 amRNSHolding in Company
28th Aug 20207:00 amRNSDirector/PDMR Shareholding
21st Aug 20209:05 amRNSSecond Price Monitoring Extn
21st Aug 20209:00 amRNSPrice Monitoring Extension
21st Aug 20207:00 amRNSHolding(s) in Company
21st Aug 20207:00 amRNSDirector/PDMR Shareholding
20th Aug 20209:05 amRNSSecond Price Monitoring Extn
20th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 202011:06 amRNSSecond Price Monitoring Extn
19th Aug 202011:00 amRNSPrice Monitoring Extension
19th Aug 20209:05 amRNSSecond Price Monitoring Extn
19th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20209:05 amRNSSecond Price Monitoring Extn
18th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSDirector/PDMR Shareholding
18th Aug 20207:00 amRNSHolding in Company
17th Aug 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.